From the analysis of the tissues collected from cohort 1, we identified that the mRNA expression of FTO increased by 2.8‐fold in the tumor tissues of patients with bladder cancer compared to their normal tissues (p < 0.001; Figure 1G). The gene discussed is FTO; the disease is urinary bladder carcinoma.